Legal & General Group
TRHC

Legal & General Group’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Legal & General Group’s Portfolio TRHC Stock Details TRHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,387
Closed -$7K – 3442
2022
Q3 		$7K Sell
1,387
-26,538
-95% -$114K ﹤0.01% 3382
2022
Q2 		$72K Sell
27,925
-175,423
-86% -$658K ﹤0.01% 2930
2022
Q1 		$1.17M Sell
203,348
-122,872
-38% -$1.1M ﹤0.01% 2190
2021
Q4 		$4.89M Buy
326,220
+168,592
+107% +$3.07M ﹤0.01% 1576
2021
Q3 		$4.13M Buy
157,628
+40,095
+34% +$1.48M ﹤0.01% 1655
2021
Q2 		$5.88M Sell
117,533
-32,144
-21% -$1.44M ﹤0.01% 1461
2021
Q1 		$6.89M Buy
149,677
+51,956
+53% +$2.48M ﹤0.01% 1416
2020
Q4 		$4.19M Buy
97,721
+23,606
+32% +$896K ﹤0.01% 1553
2020
Q3 		$3.02M Buy
74,115
+6,863
+10% +$342K ﹤0.01% 1585
2020
Q2 		$3.68M Buy
67,252
+10,864
+19% +$621K ﹤0.01% 1451
2020
Q1 		$2.93M Buy
56,388
+3,524
+7% +$191K ﹤0.01% 1410
2019
Q4 		$2.57M Buy
52,864
+3,857
+8% +$181K ﹤0.01% 1675
2019
Q3 		$2.69M Buy
49,007
+5,265
+12% +$301K ﹤0.01% 1585
2019
Q2 		$2.18M Buy
43,742
+2,359
+6% +$117K ﹤0.01% 1659
2019
Q1 		$2.33M Buy
41,383
+4,933
+14% +$294K ﹤0.01% 1626
2018
Q4 		$2.31M Buy
36,450
+318
+0.9% +$22.5K ﹤0.01% 1517
2018
Q3 		$2.91M Buy
36,132
+8,587
+31% +$629K ﹤0.01% 1517
2018
Q2 		$1.76M Buy
27,545
+2,513
+10% +$123K ﹤0.01% 1722
2018
Q1 		$980K Buy
25,032
+22,613
+935% +$792K ﹤0.01% 1891
2017
Q4 		$69K Buy
2,419
+827
+52% +$24.2K ﹤0.01% 2753
2017
Q3 		$43K Hold
1,592
– – ﹤0.01% 2959
2017
Q2 		$24K Buy
1,592
+794
+99% +$10.7K ﹤0.01% 3121
2017
Q1 		$11K Hold
798
– – ﹤0.01% 3183
2016
Q4 		$12K Buy
+798
New +$10.2K ﹤0.01% 3201

Other funds holding TRHC

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
RP
Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Legal & General Group's TRHC Position: Q4 2022 in Review

Legal & General Group sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2022, closing a stake of 1,387 shares — an estimated $7K sold.

Legal & General Group first reported a position in TRHC in Q4 2016 and held it in 24 quarters. The position peaked at $6.89M in Q1 2021. 67 funds tracked by Wall St. Rank hold TRHC as of Q4 2022.

  • Legal & General Group reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Legal & General Group sold 1,387 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2022, an estimated $7K.
  • Legal & General Group first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2016 and held it in 24 quarters.
  • Legal & General Group's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $6.89M in Q1 2021.
  • 67 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2022.

Based on Legal & General Group's 13F filing for Q4 2022, filed 14 Feb 2023.